|
MORNING SESSION
7:00 am: Breakfast
7:45 am: Welcome
David Ewing Duncan, BioAgenda 2006 Summit Host
7:50 am: Fireside Chat: Economics
In conversation with host David Ewing Duncan:
Susan Hellmann, MD, President Product Development, Genentech
8:20 am: TOPIC: Regeneration and Stem Cells
The reality of the science versus the promises made by supporters and claims by critics; and what works and doesn't work.
Moderator: Jason Pontin, Editor-in-Chief and Publisher, MIT Technology Review
Part I: Regulating Research
How Britain Has Dealt with Stem Cell Research
Lord Naren Patel of Dunkeld, MD, Chairman of the United Kingdom Stem Cell Oversight Committee; Member, House of Lords; Fellow of the Royal College of Obstetricians and Gynecologists
In conversation with Jason Pontin.
Part II: Discussion
Richard Hayes, PhD, Executive Director, Center for Genetics and Society
William Hurlbut, MD, Bioethicist; Consulting Professor, Stanford University; Member, President's Council on Bioethics
Robert N. Klein, JD, Chairman, Independent Citizens' Oversight Committee, California Institute for Regenerative Medicine; President, Klein Financial Corporation
Lord Naren Patel of Dunkeld, MD, Chairman of the United Kingdom Stem Cell Oversight Committee; Member, House of Lords; Fellow of the Royal College of Obstetricians and Gynecologists
Joan Samuelson, JD, President, Parkinson's Action Network; Parkinson's Disease patient
Stem Cell Scientist TBA
Co-Organized by the MIT Technology Review
9:40 am BioAgenda 2006 Innovator
Kari Stefansson, MD, CEO and Co-Founder, deCODE Genetics
Talks about deCODE's recent discovery of a new gene that correlates with Diabetes Type II, and how this relates to the current state of genomics: "The genetics of common disease: signatures of selection"
BioAgenda Innovators are chosen for making extraordinary discoveries and innovations during the previous year that are likely to profoundly impact society.
10:00 am: BREAK
10:25 pm: Interlude
David Helfand, PhD, Chairman, Astronomy Department, Columbia University; world-renowned astrophysicist
"Life sciences beyond the Earth: a brief demonstration"
10:50 am: TOPIC: Is the Biotech Industry Paying Off?
Four proposals for reforming drug development to benefit both patients and companies. Each panelist will offer a short "proposal", followed by a discussion.
Moderator: David Ewing Duncan, BioAgenda Founder and Editorial Director
G. Stephen Burrill, Founder & CEO, Burrill & Company
Ron Cape, PhD, Co-Founder Cetus Corporation; Biotech investor
Joan Samuelson, JD, Founder and President, Parkinson's Action Network: Parkinson's Disease patient
Raymond Woosley, MD, PhD, President, The Critical Path Institute; former Special Consultant to the Food and Drug Administration
HOMEWORK ASSIGNMENT: This topic will include the presentation of ideas generated by the "homework" assignments issued before the Summit.
11:45 am: BioAgenda Challenge
Baroness Susan Greenfield, PhD, Professor, Oxford University; Director, Royal Institution of Great Britain; Member, House of Lords
Challenge: "Science should create a 'Science Corps' to assist in solving scientific conundrums in the developing world"
Co-Organized by the Royal Institution of Great Britain
12:10 pm: TOPIC: The Haves and Have Nots of Life Sciences
About a billion people have access to the fruits of modern discoveries and innovations in life sciences. What about the other 5 billion people? Why are there gaps, and how can they be filled?
Part I: Presentation of BioAgenda White Paper Report
A summary presentation of the Institute’s first collaborative white paper, prepared with the support and input of the GAPCures Initiative, a group of leaders in business, the media, and development with a mission to study innovative ways for industry to contribute to filling in the "gaps" in providing medications to the have-nots in the world.
Brief Video: A presentation about the Ankgor Hospital for Children, a model project in Cambodia investigated by a team from GAPCures and BioAgenda.
Part II: Panel Discussion
Moderator: Robert Krulwich, JD, Network Correspondent, ABC News; Correspondent, National Public Radio's Science Unit
Rashmi Barbhaiya, PhD, CEO and Co-Founder Advinus Therapeutics; former President, R&D, Ranbaxy
Chris Hentschel, PhD, CEO, Medicines for Malaria Venture
Paul Herrling, PhD, Head of Corporate Research, Novartis; Chairman of the Board, Novartis Institute for Tropical Diseases in Singapore
Craig Nakagawa, MBA, Chief Operating Officer, VillageReach
HOMEWORK ASSIGNMENT: This topic will include the presentation of ideas generated by the "homework" assignments issued before the Summit.
Co-Organized by the Ad-Hoc Committee for the GAPCures Initiative
1:00 pm: LUNCH
AFTERNOON SESSION
2:30 pm: Interlude
Leonard Shlain, MD, Chairman of Laparoscopic Surgery, California Pacific Medical Center; Associate Professor UCSF Medical School; best-selling author of Art & Physics: Parallel Visions in Space, Time, and Light
"Sex, Time and Power: How Women's Sexuality Shaped Human Evolution"
2:55 pm: Discover Magazine Roundtable
Public Health, Bioterrorism and Pathogens
From Bioterrorism to Avian Flu and the Biohazards of Hurricanes and Other Disasters - Are We Ready?
Moderator: Stephen Petranek, Editor-in-Chief, Discover Magazine
Brook Byers, Partner, Kleiner Perkins Caufield & Byers
Elin Gursky, ScD, Principal Deputy for Biodefense, National Strategies Support Directorate, ANSER Analytic Services Inc.
Chris Hentschel, PhD, CEO, Medicines for Malaria Venture
Cynthia Schneider, PhD, Distinguished Professor in the Practice of Diplomacy, Georgetown University; Former U.S. Ambassador to The Netherlands; Art Historian
Dan Sharp, JD, President, The Royal Institution World Science Assembly (RiSci)
Senior CDC Official TBA
Co-Organized by Discover Magazine and Georgetown University's Life Sciences Initiative
The Discover Roundtable will be published in Discover Magazine in the summer of 2006.
4:00 pm: Summary of Summit, call to continue the dialogue
Host David Ewing Duncan asks the BioAgenda Innovators and Challengers to stand, and requests participants support their efforts over the coming year.
4:15 pm: Summit Closes
For Summit Participants
You are highly encouraged to participate in the following exercises:
1. Homework Assignments. Before the Summit, participants will receive a brief assignment to provide input with ideas, innovations, solutions, or comments about specific topics. Selected ideas will be printed and shared by moderators for speakers and participants to discuss.
2. Supporting Innovators and Challengers. Participants are invited to support speakers presenting BioAgenda Challenges and BioAgenda Innovators for the next year by spreading the word about their work and ideas; by holding salons and dinners on their behalf; and providing professional assistance where possible.
back to Itinerary
back to top
|
